Biosingularity
Biosingularity
Biosingularity is the automatic fact-checker for biomedical AI, providing verifiable verdicts on AI-generated claims.
About
What does Biosingularity do?
Biosingularity offers automated fact-checking for biomedical AI, verifying claims against authoritative primary sources with a deterministic verdict of pass, review, or reject, each backed by a direct link to the source record. This service is built for teams shipping biomedical AI, researchers checking references, journals and research-integrity professionals, and pharma and biotech companies. It ensures that no AI-generated biomedical information is asserted without verifiable evidence.
What industry does Biosingularity operate in?
Biosingularity operates in Biotech, MedTech, HealthTech, AI-Driven Drug Discovery, Clinical Trials, AI Governance.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.